Overblog Alle Blogs
Edit post Folge diesem Blog Administration + Create my blog
MENU

Mein Blog umfasst die aktuellesten News, Forschungsleistung, neuesten Produkte und Service von Sino Biological Inc. und die aktuelle News von Life Sciences. Sie können sich hier wissenschaftlich informieren.Willkommen zu meinem Blog.Viel Spaß!

Werbung

CD63 Antikörper

Sino Biological Inc. liefert CD63 Antikörper mit höherer Qualität und günstiger Kosten im Vergleich mit anderen globalen Lieferanten.

Weitere Informationen über CD63 Antikörper lesen Sie bitte: http://www.sinobiological.com/CD63-Antibody-g-10139.html

Produkt-Information von CD63 Antikörper

Immunogen

Recombinant Human CD63 protein (Catalog#11271-H08H)

Antibody Type Mouse Monoclonal Antibody ( Mouse mAb Service Platform )

Clone ID

10

Ig Type

Mouse IgG1

Formulation 0.2 μm filtered solution in PBS with 5% trehalose
Preparation

This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CD63 (rh CD63; Catalog#11271-H08H; P08962-1; Ala 103-Val 203). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.

Usage Guide von CD63 Antikörper

Specificity

Human CD63

 

No cross-reactivity in ELISA with

Human cell lysate (293 cell line)

Direct ELISA This antibody can be used at 0.5-1 μg/mL with the appropriate secondary reagents to detect Human CD63. The detection limit for Human CD63 is approximately 0.00975 ng/well.
Storage This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.

Verwandte Produkte & Themen von CD63 Antikörper

Related Areas:

Cardiovascular>>Platelet>>CD63

Immunology>>Adhesion Molecule>>Extracellular Matrix Molecule>>Extracellular Matrix Protein>>CD63

Immunology>>Cluster of Differentiation>>CD63

Proteins:
Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
CD63 Human CD63 / Tspan-30 / Tetraspanin-30 Protein, Recombinant 11271-H08H
CD63 Sus scrofa (Pig) CD63 / Tspan-30 / Tetraspanin-30 Protein, Recombinant 13657-W02H
Antibodies:
Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Human CD63 ELISA CD63 Antibody 11271-MM10

Hintergrund von CD63 Antikörper

CD63 antigen, also known as Granulophysin, Lysosomal-associated membrane protein 3, Melanoma-associated antigen ME491, Ocular melanoma-associated antigen, Tetraspanin-30, CD63 and Tspan-30, is a multi-pass membrane protein which belongs to thetetraspanin (TM4SF) family. Tetraspanins comprise a large superfamily of cell surface-associated membrane proteins characterized by four transmembrane domains. Tetraspanins participate in a variety of cellular processes, like cell activation, adhesion, differentiation and tumour invasion. At the cell surface, tetraspanins form networks with a wide diversity of proteins called tetraspanin-enriched microdomains (TEMs). CD63 / Tspan-30 was the first characterized tetraspanin. In addition to its presence in TEMs, CD63 / Tspan-30 is abundantly present in late endosomes and lysosomes. CD63 / Tspan-30 is expressed in melanoma and appears to be involved in regulation of motility and adhesion of melanoma cells. CD63 / Tspan-30 is associated with early stages of melanoma tumor progression. It may play a role in growth regulation. Lack of expression of CD63 in platelets has been observed in a patient with Hermansky-Pudlak syndrome (HPS). which is a genetically heterogeneous, rare, autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects.

References

  1. Smith, M. et al., 1997, Melanoma Res. 7 Suppl 2: S163-70.
  2. Chen, Z. et al., 2004, Int J Mol Med. 14 (4): 517-27.
  3. Iida,J. et al., 2005, J Transl Med. 3: 42.
  4. Kallquist,L. et al., 2008,Blood. 112 (8): 3444-54.
  5. Pols, M.S. et al., 2009, Exp Cell Res. 315 (9): 1584-92.

Primary Antibody Products

Werbung
Zurück zu Home
Diesen Post teilen
Repost0
Um über die neuesten Artikel informiert zu werden, abonnieren:
Kommentiere diesen Post